KZR logo

KZRKezar Life Sciences Inc

$7.29
$0.07
(0.95%)
Today
Closed $7.29
$0.08
(1.10%)
After Hours
Updated: 05:09 PM EDT
EarningsAug 12
Mkt Cap$53.86M
Vol616,015.00

About

Kezar Life Sciences, Inc. is a clinical-stage biopharmaceutical company which engages in the development of novel small molecule therapeutics to treat autoimmunity and cancer. Its product pipeline includes KZR-616, KZR-261, and KZR-TBD. The company was founded by John Fowler, Christopher J. Kirk, and Jack Taunton on February 19, 2015 and is headquartered in South San Francisco, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
9

Frequently Asked Questions

What is Market Cap of Kezar Life Sciences Inc?
What is the 52-week high for Kezar Life Sciences Inc?
What is the 52-week low for Kezar Life Sciences Inc?
What is Kezar Life Sciences Inc stock price today?
What was Kezar Life Sciences Inc stock price yesterday?
What is the PE ratio of Kezar Life Sciences Inc?
What is the Price-to-Book ratio of Kezar Life Sciences Inc?
What is the 50-day moving average of Kezar Life Sciences Inc?
How many employees does Kezar Life Sciences Inc have?

Advertisement|Remove ads.